Vinci Pharmaceuticals, Inc., 2026-01-26
An SEC Form D private-offering notice from Avon By The Sea, NJ, a $25,348,339 filer-stated offering target in Biotech. Filed 2026-01-26. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Specialty ophthalmic company developing EPIPLANT, a needle free drug delivery platform for retinal diseases including diabetic macular edema and intermediate age related macular degeneration.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Moove Fitness, Inc., 2026-02-10, $300K, Atlantic Highlands, NJ
- NovaBay Pharmaceuticals, Inc., 2026-01-27, $134M, Emeryville, CA
- Ensho Therapeutics, Inc., 2026-02-09, $20M, Woodcliff Lake, NJ
- Kylix Bio, Inc., 2026-01-26, $12M, Dover, DE
- Exxat, Inc., 2026-01-29, $45M, Warren, NJ
- Sarmal, Inc., 2026-01-26, $5M, La Jolla, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.